about
The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.Upregulation and biological function of transmembrane protein 119 in osteosarcomaCD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.XB130 expression in human osteosarcoma: a clinical and experimental study.Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell.Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosisHuman osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.Clinical applications in molecular imaging.Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.Interleukin-11 receptor α is overexpressed in human osteosarcoma, and near-infrared-labeled IL-11Rα imaging agent could detect osteosarcoma in mouse tumor xenografts.The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.Polydatin promotes apoptosis through upregulation the ratio of Bax/Bcl-2 and inhibits proliferation by attenuating the β-catenin signaling in human osteosarcoma cellsSTK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.
P2860
Q30651861-240285D3-FFD2-4D46-BEE9-DA79B8D57C0CQ33754048-3D537CF1-4A7D-49FF-8C82-333C398C46FFQ35506606-DD1A1F10-E3BC-43C2-A51D-55B9C7074389Q35632091-46CAC803-3FC7-427C-966C-AB1305A9348EQ35769381-EB1D9908-3CD9-45D7-962C-7B9471098D78Q35884951-3C7E64D5-F3C0-47E0-9884-65177E426A91Q36841299-4AC913D1-E071-4965-9F8E-187515F32EE1Q37311518-32AA34BC-7990-47F3-ACBA-98DE4B3D0D26Q37626756-A3A9FD6D-ACCD-4255-B743-8FA73DD01125Q37815405-D205860C-F3E4-4B04-9621-C9820E9D3B37Q38707939-83458672-E44F-4E70-9F75-F34888A3A862Q38927077-D031E49F-187E-47AB-8768-F01D33EC6E77Q40516293-636730DE-3F97-4DD8-B45E-706F8753722EQ40684757-42EAE5CA-EF76-43F5-9857-D318E35DC3A6Q41388839-87207F00-1DF9-46D0-9DA3-86DFE0C2E1A1Q43878025-B5F21746-9C24-45CA-AED8-E8E57BA79563Q44699380-D874A2E8-3BE2-45FC-A3E4-A9BD493F0DD2Q48511799-95E84532-E8DD-41A5-832C-2776DD12854CQ53262282-4F704CA4-D537-467A-967B-9249B69D29A3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic markers in osteosarcoma.
@en
Prognostic markers in osteosarcoma.
@nl
type
label
Prognostic markers in osteosarcoma.
@en
Prognostic markers in osteosarcoma.
@nl
prefLabel
Prognostic markers in osteosarcoma.
@en
Prognostic markers in osteosarcoma.
@nl
P2860
P356
P1476
Prognostic markers in osteosarcoma.
@en
P2093
Sameer Bakhshi
P2860
P304
P356
10.1586/ERA.09.186
P577
2010-02-01T00:00:00Z